Pediatric Subjects With Cirrhosis Are Not at a Higher Risk of Bleeding or Clotting due to a Rebalanced Hemostatic System

被引：0

|

作者：

Jarasvaraparn, Chaowapong ^{[1
]}

Rusch, Courtney ^{[2
]}

Stoll, Janis ^{[1
]}

Kulkarni, Sakil ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, St Louis, MO 63110 USA

[2] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA

来源：

TRANSPLANTATION | 2021年 / 105卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：S2 / S2

页数：1

相关论文

共 22 条

[21] A Phase 2b Study of Safety & Efficacy in Subjects with Acute-on-Chronic Hepatitis (AOCH) Due Either to Acute Alcoholic Hepatitis or Acute Decompensation of Cirrhosis & the Use of a Support System (ELAD®) a Human Cell-Based Biological Liver
Teperman, L.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 64 - 64
[22] Why are Higher CD34+Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors - But Not for High-Risk Neuroblastoma?
Knight, Tristan E.
Broglie, Larisa
Sharma, Akshay
Qayed, Muna
Yanik, Gregory A.
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2025, 42 (01) : 63 - 67